Inactive Instrument

Simavita Limited

Equities

SVA

AU000000SVA1

Simavita Limited : - 2019 Annual General Meeting Presentation N

November 27, 2019 at 08:25 am EST

Sydney, Australia - Simavita Limited ('Simavita' or the 'Company') (ASX: SVA) is pleased to release the attached presentation which will be delivered by its Chairman, Mr Michael Spooner, at the Company's 2019 Annual General Meeting to be held at 11.00 am this morning at the offices of K&L Gates, 1 O'Connell Street, Sydney NSW 2000.

Contact:

Tel: 21 466 653

About Simavita

Simavita (ASX: SVA) is a MedTech Company focused on the development of smart, wearable and disposable platform technologies for the health care market. Our key platform Smartz (formerly AlertPLUS) is a highly disruptive technology focused on transforming a traditional 'dumb' diaper into a smart device to help parents and carers of both infants and adults. With the support of our CDI holders, customers and employees, Simavita is absolutely committed to the business at hand; creating a commercially successful and growing corporation. www.simavita.com

Forward-Looking Information

This document may contain 'forward-looking information' within the meaning of Canadian securities laws ('forward-looking information'). This forward-looking information is given as of the date of this document. Forward-looking information relates to future events or future performance and reflects Simavita management's expectations or beliefs regarding future events. Assumptions upon which such forward-looking information is based include that Simavita will be able to successfully execute on its business plans. Many of these assumptions are based on factors and events that are not within the control of Simavita and there is no assurance they will prove to be correct. In certain cases, forward-looking information can be identified by the use of words such as 'plans', 'expects' or 'does not expect', 'is expected', 'budget', 'potential', 'scheduled', 'estimates', 'forecasts', 'intends', 'anticipates' or 'does not anticipate', or 'believes', or variations of such words and phrases or information that certain actions, events or results 'may', 'could', 'would', 'might' or 'will be taken', 'occur' or 'be achieved' or the negative of these terms or comparable terminology. By its very nature forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Simavita to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information.

Latest news about Simavita Limited

Simavita Limited Reports Earnings Results for the First Quarter Ended September 30, 2021	21-12-16	CI
Simavita Limited Reports Earnings Results for the Full Year Ended June 30, 2021	21-10-28	CI
Simavita Limited Auditor Raises 'Going Concern' Doubt	21-10-27	CI
Simavita Limited Reports Earnings Results for the Nine Months Ended March 31, 2021	21-05-31	CI
Simavita Limited Reports Earnings Results for the Half Year Ended December 31, 2020	21-02-26	CI
Simavita : Extends Capital Reduction Offer; Shares Down 6%	21-01-03	MT
Simavita : Raises Nearly $2 Million via Bond Offering for Working Capital, Interest Payment	20-12-23	MT
Simavita Limited announced that it expects to receive AUD 2.3 million in funding	20-12-22	CI
Simavita Limited Auditor Raises 'Going Concern' Doubt	20-10-06	CI
Simavita Limited Delays Audited Financial Statements for the Year Ended 30 June 2020	20-10-01	CI
Simavita Limited Reports Consolidated Earnings Results for the Year Ended June 30, 2020	20-08-27	CI
Simavita Limited announced that it has received AUD 3.01 million in funding	20-04-06	CI
Simavita Limited Reports Earnings Results for the Half Year Ended December 31, 2019	20-02-27	CI
Simavita Limited Appoints John McBain to its Board of Directors	19-11-26	CI
Simavita Limited Receives CE Mark Approval for Smartz™	19-11-25	CI
Simavita Limited Reports Consolidated and Parent Earnings Results for the Year Ended June 30, 2019	19-08-30	CI
Simavita Limited Auditor Raises 'Going Concern' Doubt	19-08-29	CI
Simavita Limited Announces the Appointment of Alan Fisher as Director	19-08-19	CI
Simavita Limited Announces Changes to its Board of Directors	19-07-23	CI
Simavita Limited Announces Consolidated Earnings Results for the Half Year Ended December 31, 2018	19-07-17	CI
Simavita Limited Announces Board Changes	19-06-26	CI
Simavita Limited announced that it expects to receive AUD 3 million in funding	19-05-09	CI
Simavita Limited Appoints Damien Haakman as Director of the Company	18-12-11	CI
Simavita Announces Resignation of Warren Bingham from the Board of Directors, Effective from December 11, 2018	18-11-25	CI
Simavita Limited announced that it has received AUD 0.1 million in funding	18-11-18	CI

Chart Simavita Limited

Duration

Period

More charts

Company Profile

Simavita Limited focuses on the sale and distribution of a range of products derived from its incontinence assessment and management technology, Smart Incontinence Management (SIM), with an emphasis on the United States, European marketplaces and Australia. The Company offers various products, which include SIM sensor, SIM pod, SIM assist application, SIM Wireless Fidelity enabling devices. The SIM pod is a wearable medical device, which connects to the SIM sensor and wirelessly transmits incontinence data to a server. The incontinence data collected is synchronized and processed with the incontinence-related observations, which are recorded through the SIM assist application. The SIM sensor is a single-use disposable device, which detects and records incontinence data. The SIM assist application is a software application, which allows caregivers to take observations and integrate them directly into the incontinence assessment record using the mobile technology.

Sector

More about the company